Channing Capital Management’s Elanco Animal Health ELAN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $9.06M | Sell |
634,770
-182,357
| -22% | -$2.6M | 0.25% | 76 |
|
2025
Q1 | $8.58M | Buy |
817,127
+85,358
| +12% | +$896K | 0.26% | 70 |
|
2024
Q4 | $8.86M | Buy |
731,769
+40,359
| +6% | +$489K | 0.24% | 78 |
|
2024
Q3 | $10.2M | Buy |
691,410
+164,909
| +31% | +$2.42M | 0.26% | 65 |
|
2024
Q2 | $7.6M | Buy |
526,501
+27,235
| +5% | +$393K | 0.21% | 84 |
|
2024
Q1 | $8.13M | Sell |
499,266
-58,955
| -11% | -$960K | 0.22% | 84 |
|
2023
Q4 | $8.32M | Buy |
558,221
+15,606
| +3% | +$233K | 0.25% | 73 |
|
2023
Q3 | $6.1M | Sell |
542,615
-43,657
| -7% | -$491K | 0.2% | 85 |
|
2023
Q2 | $5.9M | Sell |
586,272
-2,119
| -0.4% | -$21.3K | 0.18% | 99 |
|
2023
Q1 | $5.53M | Sell |
588,391
-150,074
| -20% | -$1.41M | 0.18% | 98 |
|
2022
Q4 | $9.02M | Buy |
738,465
+145,235
| +24% | +$1.77M | 0.29% | 90 |
|
2022
Q3 | $7.36M | Buy |
593,230
+197,715
| +50% | +$2.45M | 0.25% | 89 |
|
2022
Q2 | $7.76M | Buy |
395,515
+41,632
| +12% | +$817K | 0.25% | 83 |
|
2022
Q1 | $9.23M | Buy |
+353,883
| New | +$9.23M | 0.27% | 81 |
|
2021
Q1 | – | Sell |
-133,147
| Closed | -$4.08M | – | 114 |
|
2020
Q4 | $4.08M | Sell |
133,147
-50,182
| -27% | -$1.54M | 0.17% | 100 |
|
2020
Q3 | $5.12M | Sell |
183,329
-96,424
| -34% | -$2.69M | 0.28% | 91 |
|
2020
Q2 | $6M | Buy |
279,753
+58,116
| +26% | +$1.25M | 0.34% | 76 |
|
2020
Q1 | $4.96M | Sell |
221,637
-20,431
| -8% | -$457K | 0.35% | 74 |
|
2019
Q4 | $7.13M | Buy |
+242,068
| New | +$7.13M | 0.33% | 88 |
|